Order results by:
Issue | Title | |
Vol 3, No 3 (2011) | Treatment for poststroke spasticity, the use of mydocalm | Abstract similar documents |
V. A. Parfenov | ||
"... that mydocalm given in a dose of 300 to 900 mg/day may be effective in treating poststroke spasticity. ..." | ||
Vol 3, No 4 (2011) | Mechanisms in the pathogenesis of poststroke spasticity | Abstract similar documents |
E. A. Katushkina, O. E. Zinovyeva, B. S. Shenkman, N. N. Yakhno | ||
"... Objective: to study the mechanisms of poststroke spasticity and the role of structural ..." | ||
Vol 2, No 3 (2010) | Treatment for spasticity after stroke | Abstract similar documents |
S. E. Khatkova | ||
"... The epidemiology, symptomatology, pathogenesis, diagnosis of post-stroke spasticity, and its basic ..." | ||
Vol 8, No 4 (2016) | POSTSTROKE SPASTICITY: AN INDIVIDUALIZED APPROACH TO TREATMENT | Abstract similar documents |
V. A. Tolmacheva | ||
"... Poststroke spasticity is common in many patients and frequently hampers the recovery of lost motor ..." | ||
Vol 13, No 5 (2021) | Spasticity syndrome in cerebral pathology: evaluation and clinical models | Abstract PDF (Eng) similar documents |
A. P. Kovalenko, I. A. Voznyuk, V. K. Misikov | ||
"... Knowing the frequency of spasticity patterns in different muscles allows correcting the botulinum ..." | ||
Vol 1, No 2 (2009) | ACUTE BACK PAIN IN THE OUTPATIENT SETTING AND ITS TREATMENT WITH MYDOCALM AND MIRLOX | Abstract similar documents |
S. V. Verbitskaya, V. A. Parfenov, K. N. Borisov | ||
"... and mydocalm in a dose of 150 mg thrice daily. As a result of therapy, back pain disappeared or diminished ..." | ||
Vol 16, No 5 (2024) | Muscle relaxers in acute musculoskeletal back pain | Abstract similar documents |
A. Kh. Mukhametzyanova, A. I. Isaikin | ||
"... of tolperisone (Mydocalm) as monotherapy and in combination with NSAIDs for ANBP. Tolperisone (Mydocalm) has ..." | ||
Vol 14, No 1 (2022) | Treatment of spasticity in patients with the consequences of traumatic brain injury | Abstract similar documents |
A. P. Kovalenko, I. A. Vozniuk, K. M. Naumov, V. Yu. Lobzin, S. Yu. Kirtaev | ||
"... severity, suffer from pronounced spasticity, cognitive, vestibular and motor disorders. At the same time ..." | ||
Vol 4, No 1 (2012) | Neurotransmitters in the regulation of movements and in the development of spastic movement disorders | Abstract similar documents |
Andrei Anatolyevich Korolev, G A Suslova | ||
Vol 13, No 6 (2021) | Multicenter, randomized, double-blind study of the efficacy and safety of prolonged release tolperisone hydrochloride 450 mg (Mydocalm® Long, once daily) and tolperisone hydrochloride 150 mg (three times daily) for acute non-specific lower back pain | Abstract similar documents |
V. A. Parfenov, E. I. Bogdanov, V. B. Laskov, N. S. Makarov, N. V. Pisova, E. A. Salina, Zh. Yu. Chefranova, L. V. Chichanovskaya | ||
"... and safety of the new dosage form of PRTH 450 (Mydocalm® Long, once a day) in comparison with TH 150 ..." | ||
Vol 12, No 3 (2020) | Arm spasticity after stroke: botulinum toxin therapy in combination with multimodal stimulation | Abstract similar documents |
V. N. Lutsik, E. V. Slyunkova, S. V. Kotov, V. K. Misikov, E. V. Biryukova | ||
"... Post-stroke spasticity (PS) occurs in most patients with stroke and contributes to the development ..." | ||
Vol 14, No 2 (2022) | Russian consensus on the use of incobotulinumtoxinA in children with cerebral palsy for the treatment of spasticity and sialorrhea | Abstract PDF (Eng) similar documents |
A. L. Kurenkov, L. M. Kuzenkova, B. I. Bursagova, V. V. Chernikov, O. V. Agranovich, L. G. Khachatryan, V. M. Kenis, V. A. Zherebtsova, M. N. Sarzhina, N. D. Odinaeva, A. R. Artemenko, G. A. Popova, E. A. Moroshek, E. E. Tabe, A. A. Nezhelskaya, A. A. Maksimenko, L. Ya. Akhadova, M. V. Indereikin, N. V. Duibanova, L. V. Tikhonova, A. V. Sapogovskiy, Z. M. Gadzhialieva, A. V. Grigorieva, V. S. Perminov, I. D. Fedonyuk, L. M. Kolpakchi, A. Yu. Kursakova, N. A. Tsurina | ||
"... approaches for the treatment of increased muscle tone and spasticity, but also as a method of excessive ..." | ||
Vol 16, No 1 (2024) | Assessment of spasticity-related pain in cerebral palsy and the efficacy of its treatment with incobotulinumtoxin A (literature review) | Abstract similar documents |
A. L. Kurenkov, B. I. Bursagova, A. R. Artemenko | ||
"... Pain in cerebral palsy (CP) occurs in 30–60% of cases. Pain associated with spasticity (PAS ..." | ||
Vol 11, No 2S (2019): Спецвыпуск: боль в спине и конечностях | Sacroiliac joint dysfunction: clinical presentations, diagnosis, treatment | Abstract similar documents |
A. I. Isaikin, A. V. Kavelina, Yu. M. Shor, P. A. Merbaum, T. I. Shadyzheva | ||
"... denervation. They note the efficiency of using Airtal® as a NSAID and Mydocalm® as a muscle relaxant. ..." | ||
Vol 16, No 2 (2024) | Modelling long-term outcomes and mortality risk in patients with post-stroke spasticity during abobotulinum toxin injections as part of rehabilitation | Abstract similar documents |
S. E. Khatkova, A. S. Gilweg | ||
"... -stroke spasticity in terms of its impact on the risk of death from all causes and the development ..." | ||
Vol 9, No 3 (2017) | Experience with Relatox® in the combination therapy of arm and hand spasticity after stroke | Abstract similar documents |
V. V. Gusev, O. A. Lvova, T. V. Balueva | ||
"... ® in arm and hand spasticity after ischemic stroke in routine clinical practice. Patients and methods ..." | ||
Vol 14, No 2 (2022) | Muscular factor in the development of musculoskeletal pain. Treatment options | Abstract similar documents |
A. I. Isaikin, T. I. Nasonova | ||
"... of aceclofenac (Aertal®) and the muscle relaxant tolperisone (Mydocalm®) in the of MSP treatment is discussed ..." | ||
Vol 16, No 3 (2024) | Cervicobrachial syndrome: diagnostic and treatment algorithms | Abstract similar documents |
A. I. Isaykin, L. T. Akhmedzhanova, S. S. Golenkova, T. S. Koksharova, V. N. Busol, I. A. Isaykin | ||
"... -steroidal anti-inflammatory drugs — Airtal; muscle relaxants — Mydocalm) were used; therapeutic blockades ..." | ||
Vol 12, No 6 (2020) | Mapping the limb muscle motor points for targeted administration of botulinum toxin in the treatment of focal and segmental spasticity | Abstract similar documents |
A. P. Kovalenko, K. A. Sinelnikov, V. D. Shamigulov, N. N. Akhmedov, E. M. Shamina | ||
"... Spasticity treatment remains an urgent problem of modern neurorehabilitation. The targeted ..." | ||
Vol 14, No 6 (2022) | Recombinant botulinum toxin as a new stage in the development of botulinum toxin therapy. Possibilities and perspectives of use in neurological practice | Abstract similar documents |
R. K. Shikhkerimov, E. V. Istomina | ||
"... of the indications for the use of botulinum therapy in neurology is the correction of post-stroke spasticity ..." | ||
Vol 9, No 1 (2017) | Evaluation of the safety and efficacy of the Russian botulinum toxin-A relatox versus botox in treating arm and hand spasticity after ischemic stroke: A multicenter randomized trial | Abstract similar documents |
S. E. Khatkova, E. V. Kostenko, D. V. Pokhabov, A. V. Gustov, A. N. Kalyagin, N. G. Zhukova | ||
"... versus botox in treating arm and hand spasticity after ischemic stroke. Patients and methods ..." | ||
Vol 13, No 5 (2021) | Effectiveness of early abobotulinum toxin (Dysport®) injections in patients with upper limb spastic paresis after traumatic brain injury in real clinical practice: results of a multicenter observational non-interventional prospective study (Adults with post Traumatic Brain Injury (TBI) upper limb (UL) spasticity – APTULS) | Abstract similar documents |
S. E. Khatkova, V. P. Diagileva, L. V. Krylova, D. V. Pokhabov, A. G. Arutiunian | ||
"... ®) in patients with upper limb spasticity (ULS), which is one of disabling consequence traumatic's brain injuries ..." | ||
Vol 13, No 2 (2021) | Gait rehabilitation in patients with spastic hemiparesis: new opportunities | Abstract PDF (Eng) similar documents |
A. P. Kovalenko, A. S. Rodionov, D. I. Kremlyov, D. V. Averkiev, V. Yu. Lobzin, A. V. Guseva | ||
"... the effectiveness of medical ESs and spasticity treatment for gait rehabilitation in patients with spastic ..." | ||
Vol 16, No 6 (2024) | Updated and revised Russian consensus on the use of multilevel injections of abobotulinumtoxin A in children | Abstract similar documents |
A. L. Kurenkov, O. A. Klochkova, V. A. Zmanovskaya, I. V. Falkovskiy, V. M. Kenis, L. N. Vladykina, D. A. Krasavina, A. S. Nosko, L. V. Rychkova, Kh. M. Karimova, B. I. Bursagova, L. S. Namazova-Baranova, A. M. Mamedyarov, L. M. Kuzenkova, O. G. Dontzov, M. A. Ryzhenkov, M. N. Butorina, D. M. Dankov, E. V. Levitina, D. A. Popkov, S. O. Ryabykh, O. V. Agranovich, T. I. Kiseleva, O. N. Vasileva, V. P. Zykov, V. I. Mihnovich, T. A. Belogorova | ||
"... One of the modern components of complex rehabilitation of patients with spasticity is the use ..." | ||
Vol 5, No 1 (2013) | Heterogeneity of poststroke cognitive disorders: Diagnostic and therapeutic aspects | Abstract similar documents |
Igor Vladimirovich Damulin | ||
Vol 3, No 2 (2011) | Stroke and cognitive disorders | Abstract similar documents |
V. V. Zakharov, N. V. Vakhnina | ||
"... . Moreover, the prevalence of poststroke dementia, the most severe type of CDs, is 7-40% in relation ..." | ||
Vol 11, No 4 (2019) | Poststroke cognitive impairment | Abstract similar documents |
V. A. Parfenov | ||
"... patients. CI in poststroke patients is often caused not only by focal vascular lesions of the brain ..." | ||
Vol 6, No 3 (2014) | Poststroke neuroplasticity processes | Abstract similar documents |
I. V. Damulin, E. V. Ekusheva | ||
"... of different brain regions (of both the involved and intact hemisphere) in the poststroke period. Particular ..." | ||
Vol 10, No 2 (2018) | Poststroke cognitive impairment: diagnosis and treatment | Abstract similar documents |
V. A. Golovacheva, A. A. Golovacheva | ||
Vol 3, No 3 (2011) | Poststroke cognitive impairments and their therapy with ceraxon | Abstract similar documents |
N. V. Shakhparonova, A. S. Kadykov, E. M. Kashina | ||
Vol 7, No 1S (2015): Special issue "Epilepsy" | Clinical features of poststroke epileptic seizures | Abstract similar documents |
T. V. Danilova | ||
"... Poststroke epileptic seizures are detected in 30–40% of patients over 60 years of age. Objective ..." | ||
Vol 7, No 2 (2015) | Brain bioelectrical activity changes in patients with poststroke depression and apathy | Abstract similar documents |
I. V. Kichuk, E. A. Petrova, N. A. Georgievskaya | ||
"... with poststroke apathy and depressive disorders. Patients and methods. The investigation enrolled 175 patients ..." | ||
Vol 4, No 4 (2012) | Poststroke depression: prevalence, pathogenesis, diagnosis, and treatment | Abstract similar documents |
Vladimir Anatolyevich Parfenov | ||
"... , treatment, and prevention of poststroke depression. Depression develops in nearly one in every three ..." | ||
Vol 4, No 2S (2012): Сognitive and other neuropsychiatric disorders | Post-stroke disorders: pathogenetic, clinical, and therapeutic aspects | Abstract similar documents |
I. V. Damulin | ||
Vol 3, No 3 (2011) | Neuroprotective therapy for chronic cerebral ischemia and ischemic stroke in the rehabilitation period; use of cavinton | Abstract similar documents |
S. A. Rumyantseva, O. A. Sokhova, E. V. Silina | ||
"... The paper considers the expediency and efficiency of neurocytoprotection in poststroke ..." | ||
Vol 17, No 2 (2025) | Discogenic lumbar pain due to fibrous ring rupture | Abstract similar documents |
A. I. Isaykin, L. T. Akhmedzhanova, N. V. Vakhnina, I. A. Isaykin | ||
"... with NLP with RFR. Educational program, Aertal as NSAID and Mydocalm Long as muscle relaxer were effective ..." | ||
Vol 6, No 2S (2014): Special issue "Stroke" | Drug therapy and cognitive stimulation in patients with poststroke cognitive impairments | Abstract similar documents |
D.R. Khasanova, Yu.V. Zhitkova, L.M. Yu.V. | ||
"... Objective: to compare a multimodal drug approach to treating poststroke cognitive impairments (CI ..." | ||
Vol 4, No 2S (2012): Сognitive and other neuropsychiatric disorders | Cognitive impairments in patients with prior ischemic stroke | Abstract similar documents |
V. A. Parfenov, M. A. Cherdak, N. V. Vakhnina, S. V. Verbitskaya, L. Yu. Nikitina | ||
"... of the epidemiology, risk factors, pathogenesis, diagnosis, and treatment of poststroke cognitive impairment (PSCI ..." | ||
Vol 8, No 2 (2016) | Ultrasound-guided botulinum toxin injections | Abstract similar documents |
S. E. Khatkova, A. A. Balbert | ||
"... for muscular dystonia, spasticity, and other diseases accompanied by spasm, pain, and autonomic dysfunction ..." | ||
Vol 17, No 2 (2025) | 12-year experience of incobotulinumtoxinA use in neurological practice | Abstract similar documents |
N. V. Kireeva, E. G. Bukreeva, D. S. Kireev | ||
"... of secondary nonresponse. Results. BoNT-A therapy was most used for post-stroke spasticity (n=81), cervical ..." | ||
Vol 12, No 4 (2020) | The use of cannabinoids in epilepsy as an example: medical, social, and legal aspects | Abstract similar documents |
R. G. Akzhigitov, K. I. Pochigayeva, F. K. Rider, A. M. Teplyshova, S. I. Dedayev, I. A. Shpak, E. V. Pashnin, A. B. Gekht | ||
"... for the treatment of social diseases, such as epilepsy, pain syndromes, spasticity, including multiple sclerosis ..." | ||
Vol 17, No 1 (2025) | Lower spastic paraplegia combined with hydromyelia | Abstract similar documents |
E. G. Mendelevich, A. A. Kurbanova | ||
"... of the spinal cord (hydromyelia). The development of slowly progressive muscle weakness and spasticity ..." | ||
Vol 14, No 6 (2022) | The role of neurotrophic factors in the rehabilitation of children with cerebral palsy | Abstract similar documents |
N. V. Larina, A. I. Gordienko, L. L. Korsunskaya, N. V. Khimich | ||
"... -2”. The dynamics of the spasticity level, muscle strength in the paretic limbs, the level ..." | ||
Vol 12, No 5 (2020) | NMDA receptor antagonists in the treatment of neurological diseases | Abstract similar documents |
I. S. Preobrazhenskaya | ||
Vol 8, No 2 (2016) | Alzheimer's disease under the mask of stroke | Abstract similar documents |
A. A. Naumenko, N. V. Vakhnina | ||
"... Cognitive impairments (CIs) are common in poststroke patients. The basis for this condition ..." | ||
Vol 6, No 2S (2014): Special issue "Stroke" | Arterial hypertension and stroke: cardiac and neurological aspects of secondary prevention | Abstract similar documents |
L.A. Geraskina | ||
"... aspects of the current strategy of medical therapy within the secondary prevention of poststroke ..." | ||
Vol 2, No 4 (2010) | Aprroaches to reducing the cardiovascular risk in the late periods of ischemic stroke | Abstract similar documents |
A. V. Fonyakin, L. A. Geraskina, V. A. Shandalin | ||
"... of a late poststroke period should include the timely detection and adequate therapy of cardiac pathology ..." | ||
Vol 11, No 3 (2019) | Rehabilitation in acute stroke from the point of view of evidence-based medicine: possibilities of drug treatment | Abstract similar documents |
A. A. Kulesh | ||
"... 's disease is analyzed. The areas of pharmacological potentiation of poststroke rehabilitation ..." | ||
Vol 7, No 2 (2015) | The symptoms of pathological fatigue, apathy, and depression in patients after stroke | Abstract similar documents |
M. A. Kutlubaev, L. R. Akhmadeeva | ||
"... and associated with the severity of poststroke disability. The symptoms of apathy were detected in 10 ..." | ||
Vol 10, No 4 (2018) | Chronic cerebrovascular diseases: use of vinpocetine in neurological practice (Round Table proceedings) | Abstract similar documents |
V. A. Parfenov, S. A. Zhivolupov, V. V. Zakharov, L. A. Belova, O. V. Lagoda, R. G. Esin, N. V. Vakhnina, I. N. Samartsev | ||
"... , in poststroke patients. ..." | ||
Vol 8, No 2 (2016) | Neurometabolic therapy in the recovery period of ischemic stroke: impact on quality of life and cognitive functions | Abstract similar documents |
V. V. Zakharov, N. V. Vakhnina, D. O. Gromova | ||
"... to the drug support of cerebral reparative processes. It presents data on the rate and etiology of poststroke ..." | ||
Vol 2, No 1 (2010) | PREVENTION OF CARDIOVASCULAR EVENTS AFTER PRIOR ISCHEMIC STROKE: STANDARDS, REALITY, AND PROSPECTS | Abstract similar documents |
A. V. Fonyakin, L. A. Geraskina, V. A. Shandalin | ||
"... target for the prevention of cardiovascular events in the poststroke period is to more strictly observe ..." | ||
Vol 6, No 2 (2014) | Current approaches to the diagnosis, prevention, and therapy of cognitive impairments in vascular encephalopathy | Abstract similar documents |
V.Yu. Lobzin, A.Yu. Emelin, S.V. Vorobyev, I.A. Lupanov | ||
"... on the possible use of vinpocetine on poststroke day 5 are given. The basic principles of therapy for CI in VE ..." | ||
Vol 1, No 3-4 (2009) | ANTITHROMBOCYTIC THERAPY IN THE SECONDARY PREVENTION OF ISCHEMIC STROKE | Abstract similar documents |
A. V. Fonyakin, L. A. Geraskina | ||
"... are intricate since atherosclerosis is a systemic vascular disease and the poststroke period is characterized ..." | ||
Vol 5, No 4 (2013) | Outpatient management after severe stroke with dementia | Abstract similar documents |
Natalia Vyacheslavovna Pizova | ||
"... To render outpatient care to poststroke patients, particularly to those who have severe motor ..." | ||
Vol 1, No 3-4 (2009) | TREATMENT FOR ACUTE NONSPECIFIC BACK PAIN IN OUTPATIENT PRACTICE | Abstract similar documents |
O. N. Gerasimova, V. A. Parfenov | ||
"... (преимущественно мидокалм). В результате лечения боль в спине полностью прошла или уменьшилась (с 7,8±1,4 до 1,14±0 ..." | ||
Vol 2, No 4 (2010) | Management of patients with back pain in outpatient practice | Abstract similar documents |
O. N. Gerasimova, V. A. Parfenov | ||
"... ), миорелаксантами (мидокалм) и мильгаммой, использованными у части пациентов. ..." | ||
Vol 7, No 3 (2015) | The heterogeneity of vascular cognitive impairments and the issues of therapy | Abstract similar documents |
Elena Anatolyevna Katunina | ||
"... . Poststroke CIs manifest themselves acutely or subacutely. 6-27% of patients are diagnosed with dementia 3 ..." | ||
Vol 10, No 2 (2018) | Pre-stroke cognitive impairment and its impact on medication adherence | Abstract similar documents |
E. A. Kovalenko, A. N. Bogolepova | ||
"... by cognitive impairment (CI). Objective: to identify whether poststroke patients have pre-stroke cognitive ..." | ||
Vol 6, No 2S (2014): Special issue "Stroke" | Specific features of free radical processes in comorbid patients with acute stroke and transient ischemic attack | Abstract similar documents |
A.S. Orlova, E.V. Silina, S.A. Rumyantseva, V.A. Stupin, N.I. Menshova, V.A. Orlov, T.G. Sinelnikova, S.B. Bolevich | ||
"... poststroke mortality rates during a long-term follow-up. Conclusion. Stroke and TIA develop in the presence ..." | ||
Vol 3, No 4 (2011) | Cognitive functions in patients with stenotic lesions of the great arteries of the head before and after carotid endartectomy | Abstract similar documents |
O. V. Gavrilova, L. V. Stakhovskaya, S. B. Buklina, D. Yu. Usachev, V. A. Lukshin, A. Yu. Belyaev, V. V. Akhmetov, V. I. Skvortsova | ||
"... blood is supplied to which by an operated vessel and the vertebrobasilar system. Poststroke patients ..." | ||
Vol 12, No 1 (2020) | Experience with vortioxetine in the treatment of post-stroke depression | Abstract similar documents |
I. A. Strelnikova, A. A. Svetkina, Yu. D. Minina, O. V. Androfagina | ||
"... (FIM). The diagnosis of poststroke depression was established according to the Diagnostic ..." | ||
Vol 16 (2024): (Suppl. 2) | Pain in patients with neuromyelitis optica spectrum disorders | Abstract similar documents |
E. S. Novikova, A. S. Kotov, S. V. Kotov | ||
"... (11 – AQP4+ and three – AQP4-), pain due to spasticity in 6 patients (5 – AQP4+ and 1 – AQP4 ..." | ||
1 - 63 of 63 Items |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)